Senior insider sale
Chief Scientific Officer at EDGEWISE THERAPEUTICS, INC. — senior position signals high conviction
$3.60M
201.91K shares
What this filing means
RUSSELL ALAN J plans to sell 201.91K shares of EDGEWISE THERAPEUTICS, INC. valued at approximately $3.60M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/12/2025ACC: 0001950047-25-008795
DirectorOfficer· Chief Scientific Officer
Since Mar 2021
201.91K
Shares to sell
$3.60M
Approx. market value
100K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
11/12/2025
100KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/12/2025 | Exercise of options under a registered plan Cash | 100K | — |
| Total | 100K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
100K
Market value
$1.46M
8/26/2025
—Completed
Units to sell
1.91K
Market value
$25.5K
8/12/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
100K
Market value
$2.11M
11/12/2025
Total
Units
201.91K
Value
$3.60M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/26/2025 | 100K | $1.46M | — | Completed |
8/12/2025 | 1.91K | $25.5K | — | Completed |
| Planned — Approximate Date | ||||
11/12/2025 | 100K | $2.11M | NASDAQ | Planned |
| Total | 201.91K | $3.60M | ||